The 2009 World Forecasts of Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts Export Supplies
Icon Group International, Inc.
September 30, 2008 81 Pages - SKU: ICON1979738
|
|
This report was created for strategic planners, international marketing executives and export managers whose primary concern is the world market for human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact.
I have developed a methodology, based on macroeconomic and trade models, to estimate the market for human blood, prepared animal blood, toxins, cultures of micro-organisms, and similar products excluding yeasts for those firms serving the world via exports and foreign direct investment. It does so for the current year based on a variety of key historical indicators and econometric models.
|
- 1 METHODOLOGY & EXECUTIVE SUMMARY
- 1.1 Our Approach
- 1.2 The World Market: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts Export Supplies in 2009
- 1.3 The World Market: Human Blood, Prepared Animal Blood, Toxins, Cultures of Micro-Organisms, and Similar Products Excluding Yeasts by Destination in 2009
- 2 AFRICA: EXPORT SUPPLIES OF HUMAN BLOOD, PREPARED ANIMAL BLOOD, TOXINS, CULTURES OF MICRO-ORGANISMS, AND SIMILAR PRODUCTS EXCLUDING
- 2.1 Executive Summary
- 2.2 Kenya
- 2.3 Malawi
- 2.4 South Africa
- 2.5 Zambia
- 3 ASIA: EXPORT SUPPLIES OF HUMAN BLOOD, PREPARED ANIMAL BLOOD, TOXINS, CULTURES OF MICRO-ORGANISMS, AND SIMILAR PRODUCTS EXCLUDING
- 3.1 Executive Summary
- 3.2 China
- 3.3 Hong Kong
- 3.4 India
- 3.5 Indonesia
- 3.6 Japan
- 3.7 Malaysia
- 3.8 North Korea
- 3.9 Singapore
- 3.10 South Korea
- 3.11 Taiwan
- 3.12 Thailand
- 4 EUROPE: EXPORT SUPPLIES OF HUMAN BLOOD, PREPARED ANIMAL BLOOD, TOXINS, CULTURES OF MICRO-ORGANISMS, AND SIMILAR PRODUCTS EXCLUDING
- 4.1 Executive Summary
- 4.2 Austria
- 4.3 Belgium
- 4.4 Bulgaria
- 4.5 Croatia
- 4.6 Cyprus
- 4.7 Czech Republic
- 4.8 Denmark
- 4.9 Estonia
- 4.10 Finland
- 4.11 France
- 4.12 Germany
- 4.13 Greece
- 4.14 Hungary
- 4.15 Ireland
- 4.16 Italy
- 4.17 Latvia
- 4.18 Lithuania
- 4.19 Luxembourg
- 4.20 Norway
- 4.21 Poland
- 4.22 Romania
- 4.23 Russia
- 4.24 Slovakia
- 4.25 Slovenia
- 4.26 Spain
- 4.27 Sweden
- 4.28 Switzerland
- 4.29 the Netherlands
- 4.30 the United Kingdom
- 4.31 Ukraine
- 5 LATIN AMERICA: EXPORT SUPPLIES OF HUMAN BLOOD, PREPARED ANIMAL BLOOD, TOXINS, CULTURES OF MICRO-ORGANISMS, AND SIMILAR PRODUCTS
- 5.1 Executive Summary
- 5.2 Argentina
- 5.3 Brazil
- 5.4 Chile
- 5.5 Colombia
- 5.6 Mexico
- 5.7 Panama
- 5.8 Uruguay
- 6 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF HUMAN BLOOD, PREPARED ANIMAL BLOOD, TOXINS, CULTURES OF MICRO-ORGANISMS, AND
- 6.1 Executive Summary
- 6.2 Canada
- 6.3 Cuba
- 6.4 the United States
- 7 OCEANA: EXPORT SUPPLIES OF HUMAN BLOOD, PREPARED ANIMAL BLOOD, TOXINS, CULTURES OF MICRO-ORGANISMS, AND SIMILAR PRODUCTS EXCLUDING
- 7.1 Executive Summary
- 7.2 Australia
- 7.3 New Zealand
- 8 THE MIDDLE EAST: EXPORT SUPPLIES OF HUMAN BLOOD, PREPARED ANIMAL BLOOD, TOXINS, CULTURES OF MICRO-ORGANISMS, AND SIMILAR PRODUCTS
- 8.1 Executive Summary
- 8.2 Armenia
- 8.3 Iran
- 8.4 Israel
- 8.5 Jordan
- 8.6 Saudi Arabia
- 8.7 the United Arab Emirates
- 8.8 Turkey
- 9 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
- 9.1 Disclaimers & Safe Harbor
- 9.2 ICON Group Ltd. User Agreement Provisions
Share this report
Other tasks Related Markets Blood Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
